Topic

Pennsylvania

A collection of 524 issues

Work With Your Doctor to Get Crysvita (burosumab) Covered by Aetna (CVS Health) in Pennsylvania: Complete Provider Collaboration Guide

Quick Answer: Your Path to Crysvita Coverage Getting Crysvita (burosumab) covered by Aetna (CVS Health) in Pennsylvania requires close collaboration with your endocrinologist or nephrologist to document X-linked hypophosphatemia (XLH) diagnosis and failed conventional therapy. The fastest path: (1) gather complete diagnostic records (genetic testing, low serum phosphorus, radiographic evidence)

How to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Timeline and Appeals Guide

Answer Box: Getting Helixate Covered in Pennsylvania Important Update: Helixate NexGen and related Kogenate FS have been discontinued by Bayer. Blue Cross Blue Shield Pennsylvania plans now require prior authorization for alternative factor VIII products like Kovaltry, Advate, or Jivi. The fastest path to approval: (1) Have your hematologist submit

How to Get Breyanzi (lisocabtagene maraleucel) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Fastest Path to Breyanzi Coverage with Cigna in Pennsylvania To get Breyanzi (lisocabtagene maraleucel) covered by Cigna in Pennsylvania: (1) Have your CAR-T center submit prior authorization through Cigna's LifeSOURCE transplant program with complete documentation of diagnosis, prior therapy failures, and facility certification; (2) If denied,

How to Get Elevidys Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide with Appeals Process

Answer Box: To get Elevidys covered by Blue Cross Blue Shield in Pennsylvania, you need: 1) Confirmed DMD genetic testing showing pathogenic mutation, 2) Age ≥4 years with negative anti-AAVrh74 antibodies, 3) Prior authorization through your BCBS plan's electronic portal (Availity for Highmark, IBX portal for Independence). Most

How to Get Taltz (Ixekizumab) Covered by Cigna in Pennsylvania: Prior Authorization Guide and Appeal Strategies

Answer Box: Getting Taltz (Ixekizumab) Covered by Cigna in Pennsylvania Cigna typically requires prior authorization and step therapy before approving Taltz (ixekizumab) for psoriasis, psoriatic arthritis, or ankylosing spondylitis. You'll usually need to try TNF inhibitors like adalimumab biosimilars or Enbrel first. If denied, Pennsylvania's new

How to Get Lamzede (velmanase alfa-tycv) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide

Quick Answer: Blue Cross Blue Shield requires prior authorization for Lamzede (velmanase alfa-tycv) in Pennsylvania. You'll need confirmed alpha-mannosidosis diagnosis with enzyme activity below 11% of normal, documentation of non-CNS manifestations, and agreement to monitor for infusion reactions. If denied, Pennsylvania's new external review program overturns

How to Get Thiola/Thiola EC (Tiopronin) Covered by Cigna in Pennsylvania: Complete Prior Authorization Guide

Quick Answer: Getting Thiola/Thiola EC Approved by Cigna in Pennsylvania Cigna requires prior authorization for Thiola/Thiola EC (tiopronin) and typically places it on a specialty tier with step-therapy requirements. Your fastest path to approval: 1) Document failed alkalinization therapy (potassium citrate, high fluid intake) with continued stone formation,

The Complete Requirements Checklist to Get Myalept (Metreleptin) Covered by Cigna in Pennsylvania

Answer Box: Getting Myalept (Metreleptin) Covered by Cigna in Pennsylvania Who qualifies: Patients with confirmed generalized lipodystrophy experiencing metabolic complications despite standard therapy. Fastest path to approval: 1. Confirm generalized lipodystrophy diagnosis (ICD-10: E88.12) with endocrinologist 2. Document failed diet counseling plus optimized diabetes/lipid treatments 3. Submit complete

Renewing Xospata (Gilteritinib) Approval with UnitedHealthcare in Pennsylvania: Complete Timeline and Documentation Guide

Answer Box: Renewing Xospata Coverage with UnitedHealthcare in Pennsylvania To renew Xospata (gilteritinib) approval with UnitedHealthcare in Pennsylvania, start the process 30 days before your current authorization expires. You'll need recent oncology notes showing disease response or stability, updated FLT3 mutation documentation, and evidence of tolerability. Submit through

Getting Zanzalintinib (XL092) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Appeals Guide with Forms and External Review

Answer Box: Getting Zanzalintinib (XL092) Covered by Blue Cross Blue Shield in Pennsylvania Zanzalintinib (XL092) is an investigational multi-target TKI from Exelixis with no FDA approval, making Blue Cross Blue Shield coverage challenging but not impossible. Fastest path: Submit a medical necessity appeal through your Blue Cross Blue Shield plan&